Prediction of incomplete primary debulking surgery in patients with advanced ovarian cancer: An external validation study of three models using computed tomography

被引:19
作者
Rutten, Iris J. G. [1 ,2 ]
van de Laar, Rafli [1 ,2 ]
Kruitwagen, Roy F. P. M. [1 ,2 ]
Bakers, Frans C. H. [3 ]
Ploegmakers, Marieke J. M. [4 ]
Pappot, Teun W. F. [5 ]
Beets-Tan, Regina G. H. [2 ,3 ,6 ]
Massuger, Leon F. A. G. [7 ]
Zusterzeel, Petra L. M. [7 ]
Van Gorp, Toon [1 ,2 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Obstet & Gynecol, NL-6202 AZ Maastricht, Netherlands
[2] Maastricht Univ, GROW Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Netherlands
[3] Maastricht Univ, Med Ctr, Dept Radiol, NL-6202 AZ Maastricht, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, NL-6500 HB Nijmegen, Netherlands
[5] Rijnstate Hosp, Dept Radiol, NL-6800 TA Arnhem, Netherlands
[6] Netherlands Canc Inst, Dept Radiol, NL-1006 BE Amsterdam, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, NL-6500 HB Nijmegen, Netherlands
关键词
External validation; Prediction models; Epithelial ovarian cancer; Complete primary cytoreductive surgery; Computed tomography; ADVANCED EPITHELIAL OVARIAN; SUBOPTIMAL PRIMARY CYTOREDUCTION; PERITONEAL CANCER; PROSPECTIVE TRIAL; FALLOPIAN-TUBE; STAGE-III; CT-SCAN; CARCINOMA; RESECTABILITY; CHEMOTHERAPY;
D O I
10.1016/j.ygyno.2015.11.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To test the ability of three prospectively developed computed tomography (CT) models to predict incomplete primary debulking surgery in patients with advanced (International Federation of Gynecology and Obstetrics stages III-IV) ovarian cancer. Methods. Three prediction models to predict incomplete surgery (any tumor residual > 1 cm in diameter) previously published by Ferrandina (models A and B) and by Gerestein were applied to a validation cohort consisting of 151 patients with advanced epithelial ovarian cancer. All patients were treated with primary debulking surgery in the Eastern part of the Netherlands between 2000 and 2009 and data were retrospectively collected. Three individual readers evaluated the radiographic parameters and gave a subjective assessment. Using the predicted probabilities from the models, the area under the curve (AUC) was calculated which represents the discriminative ability of the model. Results. The AUC of the Ferrandina models was 0.56, 0.59 and 0.59 in model A, and 0.55, 0.60 and 0.59 in model B for readers 1, 2 and 3, respectively. The AUC of Gerestein's model was 0.69, 0.61 and 0.69 for readers 1, 2 and 3, respectively. AUC values of 0.69 and 0.63 for reader 1 and 3 were found for subjective assessment. Conclusions. Models to predict incomplete surgery in advanced ovarian cancer have limited predictive ability and their reproducibility is questionable. Subjective assessment seems as successful as applying predictive models. Present prediction models are not reliable enough to be used in clinical decision-making and should be interpreted with caution. (c) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:22 / 28
页数:7
相关论文
共 34 条
[1]   Ovarian cancer surgical resectability: Relative impact of disease, patient status, and surgeon [J].
Aletti, GD ;
Gostout, BS ;
Podratz, KC ;
Cliby, WA .
GYNECOLOGIC ONCOLOGY, 2006, 100 (01) :33-37
[2]   Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer [J].
Axtell, Allison E. ;
Lee, Margaret H. ;
Bristow, Robert E. ;
Dowdy, Sean C. ;
Cliby, William A. ;
Raman, Steven ;
Weaver, John P. ;
Gabbay, Mojan ;
Ngo, Michael ;
Lentz, Scott ;
Cass, Ilana ;
Li, Andrew J. ;
Karlan, Beth Y. ;
Holschneider, Christine H. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (04) :384-389
[3]   Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer [J].
Borley, J. ;
Wilhelm-Benartzi, C. ;
Yazbek, J. ;
Williamson, R. ;
Bharwani, N. ;
Stewart, V. ;
Carson, I. ;
Hird, E. ;
McIndoe, A. ;
Farthing, A. ;
Blagden, S. ;
Ghaem-Maghami, S. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 (06) :843-849
[4]  
Bristow RE, 2000, CANCER, V89, P1532, DOI 10.1002/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO
[5]  
2-A
[6]  
Byrom J, 2002, BJOG-INT J OBSTET GY, V109, P369, DOI 10.1111/j.1471-0528.2002.01216.x
[7]   What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? [J].
Chi, D. S. ;
Eisenhauer, E. L. ;
Lang, J. ;
Huh, J. ;
Haddad, L. ;
Abu-Rustum, N. R. ;
Sonoda, Y. ;
Levine, D. A. ;
Hensley, M. ;
Barakat, R. R. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (02) :559-564
[8]   Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study [J].
De Angelis, Roberta ;
Sant, Milena ;
Coleman, Michel P. ;
Francisci, Silvia ;
Baili, Paolo ;
Pierannunzio, Daniela ;
Trama, Annalisa ;
Visser, Otto ;
Brenner, Hermann ;
Ardanaz, Eva ;
Bielska-Lasota, Magdalena ;
Engholm, Gerda ;
Nennecke, Alice ;
Siesling, Sabine ;
Berrino, Franco ;
Capocaccia, Riccardo .
LANCET ONCOLOGY, 2014, 15 (01) :23-34
[9]   The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma [J].
Dowdy, SC ;
Mullany, SA ;
Brandt, KR ;
Huppert, BJ ;
Cliby, WA .
CANCER, 2004, 101 (02) :346-352
[10]   Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO) [J].
du Bois, Andreas ;
Reuss, Alexander ;
Pujade-Lauraine, Eric ;
Harter, Philipp ;
Ray-Coquard, Isabelle ;
Pfisterer, Jacobus .
CANCER, 2009, 115 (06) :1234-1244